Thomas Maeder, Consulting Industry Analyst

Accelerating Time to Market with Modern Clinical Evidence Strategies

By Thomas Maeder, Consulting Industry Analyst / July 22, 2026

Turning Innovation into Clinical Advantage for Faster Patient Access The process of biopharmaceutical clinical evidence development is undergoing dramatic change. Technological innovation, novel development strategies, […]

Accelerating Time to Market with Modern Clinical Evidence Strategies Read More »

Developing Med Tech Clinical Evidence: Challenges and New Approaches

By Thomas Maeder, Consulting Industry Analyst / February 12, 2024

An Axendia Voice of The Customer Report The need for clinical evidence on medical devices is steadily increasing – for regulatory submissions, postmarket surveillance, reimbursement,

Developing Med Tech Clinical Evidence: Challenges and New Approaches Read More »

Search

Search for: